169 related articles for article (PubMed ID: 2253221)
1. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.
Siegall CB; Schwab G; Nordan RP; FitzGerald DJ; Pastan I
Cancer Res; 1990 Dec; 50(24):7786-8. PubMed ID: 2253221
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
Siegall CB; FitzGerald DJ; Pastan I
J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.
Siegall CB; Nordan RP; FitzGerald DJ; Pastan I
Mol Cell Biol; 1990 Jun; 10(6):2443-7. PubMed ID: 2160579
[TBL] [Abstract][Full Text] [Related]
4. Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin.
Siegall CB; FitzGerald DJ; Pastan I
Curr Top Microbiol Immunol; 1990; 166():63-9. PubMed ID: 2127396
[No Abstract] [Full Text] [Related]
5. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9738-42. PubMed ID: 3264406
[TBL] [Abstract][Full Text] [Related]
6. Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin.
Boayue KB; Gu L; Yeager AM; Kreitman RJ; Findley HW
Leukemia; 1998 Feb; 12(2):182-91. PubMed ID: 9519780
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein.
FitzGerald DJ; Fryling CM; Zdanovsky A; Saelinger CB; Kounnas M; Winkles JA; Strickland D; Leppla S
J Cell Biol; 1995 Jun; 129(6):1533-41. PubMed ID: 7790352
[TBL] [Abstract][Full Text] [Related]
8. Targeting growth factor receptors with fusion toxins.
Kreitman RJ; FitzGerald D; Pastan I
Int J Immunopharmacol; 1992 Apr; 14(3):465-72. PubMed ID: 1319965
[TBL] [Abstract][Full Text] [Related]
9. HER4 expression correlates with cytotoxicity directed by a heregulin-toxin fusion protein.
Siegall CB; Bacus SS; Cohen BD; Plowman GD; Mixan B; Chace D; Chin DM; Goetze A; Green JM; Hellström I
J Biol Chem; 1995 Mar; 270(13):7625-30. PubMed ID: 7535774
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
Fitzgerald D; Pastan I
Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice.
Siegall CB; Kreitman RJ; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jun; 51(11):2831-6. PubMed ID: 1851660
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.
Ogata M; Chaudhary VK; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4215-9. PubMed ID: 2657746
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin.
Puri RK; FitzGerald D; Leland P; Kozak RW; Pastan I
Cell Immunol; 1992 Sep; 143(2):324-34. PubMed ID: 1511480
[TBL] [Abstract][Full Text] [Related]
14. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin.
Maini A; Hillman G; Haas GP; Wang CY; Montecillo E; Hamzavi F; Pontes JE; Leland P; Pastan I; Debinski W; Puri RK
J Urol; 1997 Sep; 158(3 Pt 1):948-53. PubMed ID: 9258124
[TBL] [Abstract][Full Text] [Related]
16. A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin.
Debinski W; Puri RK; Kreitman RJ; Pastan I
J Biol Chem; 1993 Jul; 268(19):14065-70. PubMed ID: 8314773
[TBL] [Abstract][Full Text] [Related]
17. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein.
Husain SR; Obiri NI; Gill P; Zheng T; Pastan I; Debinski W; Puri RK
Clin Cancer Res; 1997 Feb; 3(2):151-6. PubMed ID: 9815666
[TBL] [Abstract][Full Text] [Related]
18. Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia.
Kreitman RJ; Chaudhary VK; Kozak RW; FitzGerald DJ; Waldman TA; Pastan I
Blood; 1992 Nov; 80(9):2344-52. PubMed ID: 1421405
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas exotoxin conjugated to monoclonal antibody MRK16 specifically kills multidrug resistant cells in cultured renal carcinomas and in MDR-transgenic mice.
Mickisch GH; Pai LH; Siegsmund M; Campain J; Gottesman MM; Pastan I
J Urol; 1993 Jan; 149(1):174-8. PubMed ID: 8417204
[TBL] [Abstract][Full Text] [Related]
20. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4.
Debinski W; Obiri NI; Pastan I; Puri RK
J Biol Chem; 1995 Jul; 270(28):16775-80. PubMed ID: 7622490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
